The deadly Mpox infection has now jumped outside Africa, infecting people in Sweden, Pakistan-Occupied Kashmir (PoK), Singapore and Thailand. Formerly called Monkeypox, the disease is primarily identified by a skin rash and lesions. According to the World Health Organization (WHO), early symptoms include fever, muscle aches, and sore throat. These are soon followed by skin and mucosal rashes, which typically appear within one week of exposure, but can take up to 21 days. The symptoms usually last for two to four weeks.Dr Shifa Yadav, a Consultant Dermatologist at Artemis Hospital, Delhi, explains that Mpox lesions can be painful unlike those that form in other skin-related infections. They often create a crust before healing. They also leave scars that are similar to those seen in chickenpox, eventually fading over time. Dr Yadav advises against scratching or picking at the rash, stressing the importance of keeping the skin hydrated with general moisturizers. While the rashes can leave scars, treatments such as topical creams and, in more advanced cases, laser therapy are recommended for recovery.Last week, the WHO classified Mpox as a public health emergency of international concern after more than 17,000 cases of the deadlier strain were found across the African continent. Earlier this week, Kerala Health Minister Veena George announced that the state is stepping up precautions against Mpox in line with central directives. "As per central guidelines, surveillance teams are now active at all airports in the state. Passengers arriving from countries with reported cases are advised to report symptoms immediately at the airport," said the minister. With new cases reported in some countries, the state remains on high alert. While anyone can contract MPOX, certain groups are at a higher risk of developing severe illness and complications. Dr Meenakshi Jain, Director - Internal Medicine, Max Hospital, Patparganj explains, "MPox severity varies by age, health status, and other factors, with certain groups being more vulnerable to severe illness and complications. These vulnerable populations require special attention and care to prevent adverse health outcomes and these groups include children, the elderly, pregnant women, immunocompromised individuals and people with chronic disease.